Transdermal Delivery of a Hydrogen Sulphide Donor, ADT-OH Using Aqueous Gel Formulations for the Treatment of Impaired Vascular Function: an Ex Vivo Study.

MLA

Marwah, Mandeep Kaur, et al. “Transdermal Delivery of a Hydrogen Sulphide Donor, ADT-OH Using Aqueous Gel Formulations for the Treatment of Impaired Vascular Function: An Ex Vivo Study.” Pharmaceutical Research, vol. 39, no. 2, Feb. 2022, pp. 341–52. EBSCOhost, https://doi.org/10.1007/s11095-021-03164-z.

APA

Marwah, M. K., Shokr, H., Sanchez-Aranguren, L., Badhan, R. K. S., Wang, K., & Ahmad, S. (2022). Transdermal Delivery of a Hydrogen Sulphide Donor, ADT-OH Using Aqueous Gel Formulations for the Treatment of Impaired Vascular Function: an Ex Vivo Study. Pharmaceutical Research, 39(2), 341–352. https://doi.org/10.1007/s11095-021-03164-z

Chicago

Marwah, Mandeep Kaur, Hala Shokr, Lissette Sanchez-Aranguren, Raj Kumar Singh Badhan, Keqing Wang, and Shakil Ahmad. 2022. “Transdermal Delivery of a Hydrogen Sulphide Donor, ADT-OH Using Aqueous Gel Formulations for the Treatment of Impaired Vascular Function: An Ex Vivo Study.” Pharmaceutical Research 39 (2): 341–52. doi:10.1007/s11095-021-03164-z.